Navigation Links
Drug rescues memory lost to Alzheimer's disease
Date:7/14/2009

Irvine, Calif., July 14, 2009 A drug similar to one used in clinical trials for treatment of rheumatoid arthritis and psoriasis has been found to rescue memory in mice exhibiting Alzheimer's symptoms.

The discovery by UC Irvine scientists offers hope that a new treatment may be on the horizon for people in the early stages of Alzheimer's, the leading cause of elderly dementia afflicting more than 5 million people in the U.S. and for which no cure exists.

The drug, called PMX205, prevented inflamed immune cells from gathering in brain regions with Alzheimer's lesions called amyloid plaques. Cell inflammation in these areas accelerates neuron damage, exacerbating the disease.

"We used a multidisciplinary approach combining an understanding of immunology and neurobiology to uncover a completely different target than other therapies," said Andrea Tenner, lead author of the study that led to the findings and a molecular biology & biochemistry professor at UCI.

Study results are reported in the July 15 edition of the Journal of Immunology.

For 12 weeks, Tenner and colleagues added PMX205 to the drinking water of mice genetically altered to develop age-related Alzheimer's-like symptoms. The treatment occurred at an age when plaques were accumulating in their brains.

Scientists gave the treated mice learning and memory tests and then examined their brains for evidence of the disease. Alzheimer's mice that were not given the drug performed significantly worse on the test than normal mice. But in all but one case the treated Alzheimer's mice performed almost as well as the normal mice. Those with the rescued cognitive ability had more than 50 percent fewer Alzheimer's lesions and inflammatory immune cells than the untreated diseased mice.

PMX53, a similar drug that can be taken orally, passed Phase 1 human clinical trials for safety with no major problems reported. Possible side effects include an increased susceptibility to some infections. PMX205 is a modified version that may be more potent for treatment of brain disorders.

"This approach may work even better if combined with treatments targeting other problems in the Alzheimer's brain," said Tenner, also a professor of pathology and neurobiology & behavior, as well as a member of UCI's Institute for Immunology and Institute for Memory Impairments and Neurological Disorders, or UCI MIND.


'/>"/>

Contact: Jennifer Fitzenberger
jfitzen@uci.edu
949-824-3969
University of California - Irvine
Source:Eurekalert

Related medicine news :

1. Petfinder.com Foundation Rescues 500 Shelters and Rescue Groups Nationwide with $1 Million Worth of Generators
2. Memory test and PET scans detect early signs of Alzheimers
3. Brown professor continues debate over recovered memory
4. More Evidence That Caffeine Can Jolt Memory
5. Caffeine reverses memory impairment in Alzheimers mice
6. On Memory, Older Americans Outsmart the English
7. Sleep May Be Essential for Long-Term Memory
8. Transplant drug stimulates immune memory
9. Generation of a severe memory-deficit mutant mouse by exclusively eliminating the kinase activity of CaMKIIalpha
10. Depression may increase Alzheimers risk in people with memory problems
11. Penn study demonstrates new way to boost immune memory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... ... “The Octagon of Spiritual Balances”: a guide for the Christian seeking ... published author, Pastor Bernard J. Weathers, pastor of Word of Faith Ministries, in Colonia, ... and a master degree in theology. , ““The Octagon of Spiritual Balances” exposes the ...
(Date:1/24/2017)... ... January 23, 2017 , ... The Pharmacy ... 20, with the bipartisan original co-sponsorship of nearly one-quarter of the U.S. House ... National Association of Chain Drug Stores (NACDS) strongly backs the legislation. , “NACDS ...
(Date:1/24/2017)... ... January 23, 2017 , ... ... with the acquisitions of two personal care service companies: Padre Home Health in ... effective January 1, 2017. , Well regarded in their respective markets, these two ...
(Date:1/24/2017)... ... ... The National Council of Alcoholism and Drug Dependence ( NCADD ), in ... to designate the last full week of January as National Drug and Alcohol Facts ... As a community, we can advocate for effective treatment, but also especially effective ...
(Date:1/23/2017)... ... January 23, 2017 , ... Ultimate Medical ... Education Summit to be held March 23-25, 2017 in Tampa, and reminded educators ... , The keynote speakers include Dr. Michelle R. Weise, executive director of the ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 2017 LifeVac, the revolutionary device that has ... prevented choking deaths, welcomes Steve Way , comedian, ... team as Official Spokesperson. "We are ... said Arthur Lih , Founder and CEO of ... his mission to raise awareness about the physically disabled ...
(Date:1/23/2017)... , Jan. 23, 2017  Allergan plc, (NYSE: ... its continued support of the International Headache Academy (IHA). Designed ... neurologists and research scientists, IHA offers a three-day, intensive overview ... that Allergan has been the sole sponsor since the inception ... 2013, and iHEAD in Europe in ...
(Date:1/23/2017)... -- Varias proteínas clave que impulsan ... y el riesgo de diálisis están poco reguladas ... Resverlogix Corp. ("Resverlogix" o "la compañía") (TSX: ... en fase 1 con sede en Nueva Zelanda con ... datos demostraron unos resultados importantes en la reducción de ...
Breaking Medicine Technology: